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Background
We tested the hypothesis that therapeutic vaccination
against HIV-1 can lead to an increase in the frequency and
suppressive function of regulatory, CD4+ T cells (Treg).
Methods
HIV-1(+) subjects on ART (n = 17) were enrolled in a
phase I therapeutic vaccine trial where they received 2
doses of autologous dendritic cells loaded with HIV-1
peptides. Peripheral blood mononuclear cells (PBMC)
obtained from the subjects pre- and post-vaccine, and
from normal controls (NC) were stained with antibodies
specific for Treg (CD4+CD25hiFOXP3+), CD45RO, GITR,
and CTLA4 and assayed by flow cytometry. PBMC pre and
post-vaccine from 7 subjects were also evaluated for poly-
functionality using a flow cytometry-based, CD8+ T cell
intracellular cytokine staining assay for 5 immune media-
tors after stimulation with Gag peptide, staphylococcal
enterotoxin B (SEB) and medium alone. Treg were
depleted in one set, and total vaccine response (post-vac-
cine - pre-vaccine) was compared in the Treg(+) and Treg-
depleted (Treg-) sets.
Results
After vaccination, 12/17 subjects had increased Treg fre-
quency from 0.74% to 1.2% (p = 0.06); the median
increase was 30%. Of the 11 patients whose CD8+ T cells
did not respond to the vaccine by an increase in produc-
tion of interferon γ (ELISPOT assay), 7 (64%) had
increased frequencies of Treg. Although there was no sig-
nificant change in CD8+ T cell polyfunctionality after vac-
cination, depletion of Treg resulted in increased
polyfunctionality post-vaccine (p = 0.029), with the per-
centage of CD8+ T cells producing more than 1 immune
mediator increasing to more than twice the pre-vaccine
levels. There was no difference in polyfunctionality in the
Treg(+) and Treg(-) sets when stimulated with SEB, imply-
ing specificity of suppression to HIV-1 antigens.
Conclusion
Therapeutic immunization against HIV-1 causes a modest
increase in Treg frequency and a significant increase in
HIV-1-specific, Treg suppressive function. The role of Treg
should be considered in immunotherapeutic trials of HIV-
1 infection.
from AIDS Vaccine 2009
Paris, France. 19–22 October 2009
Published: 22 October 2009
Retrovirology 2009, 6(Suppl 3):O21 doi:10.1186/1742-4690-6-S3-O21
<supplement> <title> <p>AIDS Vaccine 2009</p> </title> <editor>Anna Laura Ross</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1742-4690-6-S3-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1471-2105-10-S12-info.pdf</url> </supplement>
This abstract is available from: http://www.retrovirology.com/content/6/S3/O21
© 2009 Macatangay et al; licensee BioMed Central Ltd. 